Silicon Laboratories, Inc. $SLAB Shares Sold by Northern Trust Corp

Key Points

• Northern Trust Corp has reduced its stake in Silicon Laboratories, Inc. by 3.6%, owning approximately 1.23% of the company after selling 15,074 shares in the 1st quarter.
• Silicon Laboratories experienced a 32.6% increase in revenue year-over-year, reporting $192.85 million for the last quarter, and earnings per share (EPS) of $0.11, exceeding analysts' estimates.
• Wall Street analysts have varied ratings on Silicon Laboratories, with a consensus of a "Moderate Buy" and a target price of $151.13, reflecting a mixed outlook for the company's stock.

Northern Trust Corp lowered its stake in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 3.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 399,933 shares of the semiconductor company's stock after selling 15,074 shares during the quarter. Northern Trust Corp owned about 1.23% of Silicon Laboratories worth $45,020,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Raymond James Financial Inc. increased its holdings in Silicon Laboratories by 0.4% in the 1st quarter. Raymond James Financial Inc. now owns 115,154 shares of the semiconductor company's stock worth $12,963,000 after buying an additional 419 shares during the period. American Century Companies Inc. increased its holdings in Silicon Laboratories by 48.7% in the 1st quarter. American Century Companies Inc. now owns 510,178 shares of the semiconductor company's stock worth $57,431,000 after buying an additional 167,047 shares during the period. Fox Run Management L.L.C. acquired a new position in Silicon Laboratories in the 1st quarter worth approximately $625,000. Caitong International Asset Management Co. Ltd acquired a new position in Silicon Laboratories in the 1st quarter worth approximately $77,000. Finally, Russell Investments Group Ltd. increased its holdings in Silicon Laboratories by 80.3% in the 1st quarter. Russell Investments Group Ltd. now owns 37,121 shares of the semiconductor company's stock worth $4,179,000 after buying an additional 16,538 shares during the period.

Insider Activity

In other news, SVP Brandon Tolany sold 8,000 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the transaction, the senior vice president owned 62,328 shares in the company, valued at $9,051,895.44. This trade represents a 11.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a report on Wednesday, May 14th. Needham & Company LLC reiterated a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a report on Wednesday, May 14th. Morgan Stanley lowered their price objective on Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 6th. KeyCorp lifted their target price on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Finally, Stifel Nicolaus lifted their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a "buy" rating in a report on Friday, July 18th. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $151.13.

Silicon Laboratories Price Performance

NASDAQ:SLAB opened at $139.66 on Thursday. The firm has a market cap of $4.58 billion, a price-to-earnings ratio of -43.37 and a beta of 1.48. The company has a 50 day moving average price of $139.05 and a 200-day moving average price of $127.83. Silicon Laboratories, Inc. has a 1-year low of $82.82 and a 1-year high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The firm had revenue of $192.85 million for the quarter, compared to analyst estimates of $192.57 million. During the same quarter last year, the firm posted ($0.56) EPS. The business's revenue was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, sell-side analysts anticipate that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current fiscal year.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.